In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...
ImmunityBio commands a premium valuation on the promise of Anktiva, a chemo-free immunotherapy platform showing early ...
Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...
University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found cell metabolism plays a critical role in determining how lung cancer ...
Surprising way cancer cells clear problematic proteins in the brain For some time, we've known that it's rare to see people with both cancer and Alzheimer's disease. Now, scientists believe they may ...
Scientists at Oregon State University have developed a new nanomaterial that triggers a pair of chemical reactions inside cancer cells, killing the cells via oxidative stress while leaving healthy ...
Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a treatment could be difficult. By Gina Kolata Is there a way to use the body’s ...
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC is also more likely to metastasize, or travel through the bloodstream ...
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which ...
Researchers at the Keck School of Medicine of University of Southern California (USC) have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response ...
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center has named Edith Ballard, DHI, vice president of revenue cycle, according to a post on her LinkedIn page. Dr. Ballard joins the cancer ...
The researchers used lipid nanoparticles (LNPs) to deliver cyclic GMP-AMP (cGAMP) synthase (cGAS) mRNA to cancer cells. This results in production of the endogenous stimulator of interferon genes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results